Heart disease is the leading cause of death for men and woman in the United States.
This year more then 1.2 million people will have a heart attack. While there are warning signs and risk factors, heart disease can hit anyone.
Heart attacks and other types of heart disease occur when coronary arteries become clogged with fatty deposits, resulting in coronary artery disease (CAD). Until recently there was no way outside of traditional imaging tests, to measure artery health, but the Corus CAD is challenging that. Imaging scans are invasive and expose people to radiation thus their use is limited.
The Corus CAD is a gene expression test that uses messenger RNA from a gene set in blood cells to determine whether or not patients have coronary artery blockages. Patients are given a simple blood test that delivers a score on a scale of one to forty. The higher the score the more likely you are to have blockages. This knowledge enables your physician to take extra precautions and book follow-up tests that can potentially save your life.
This test is available to any non-diabetic patient with typical or atypical symptoms of coronary artery disease regardless of age. Medicare coverage is available and non-insurance patient assistance is available.